US FDA declines to approve Applied Therapeutics' genetic disease drug
Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...
FDA probes blood cancer risk from bluebird's gene therapy, weighs regulatory action
The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...
Soup Recall Update as FDA Sets Highest Risk Level
A soup mix recall issued this month has been updated by the U.S. Food and Drug Administration ( FDA) as a Class I risk, the ...
Carrots, ice cream and more items recalled by the FDA. Here's the list for November 2024
The FDA removed the following items from store shelves in November: HH Fresh Trading Enoki Mushrooms: Potential to be ...
FDA Expands Carrot Recall Linked to E. Coli: 39 Illnesses, 15 Hospitalizations Reported
The FDA expanded the recall on November 21 after 39 cases of illness, resulting in 15 hospitalizations and one death, have ...
Every Active Food Recall Classified Highest Risk This Month
Numerous food recalls have been granted the highest warning level offered by the U.S. Food and Drug Administration ( FDA) so ...
A Short Lesson in Drug Competition
See the new treatment that will break a Pfizer monopoly on a drug for heart disease.
Here's Why Food Recalls Have Been On The Rise In 2024
If you've been paying attention to the news, you've likely noticed the never-ending cascade of food recalls affecting our ...
FDA greenlights study of marijuana as PTSD-treatment for vets
A clinical trial study will give vets medical and commercial-grade cannabis products to look at “real-world” use and its ...
CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders On track to report topline data from the RewinD-LB ...
JD Supra10h
FDA Provides Perspective on Goals and Challenges for Regulation of Artificial Intelligence in Medical Devices, Drug Design, and Clinical Research
A recent article authored by Haider J. Warraich, MD; Troy Tazbaz; and Robert M. Califf, MD in the Journal of the American ...
The Daily Item16h
Danville alum tapped to lead FDA
President-elect Donald Trump on Friday nominated Dr. Marty Makary to lead the Food and Drug Administration, selecting a surgeon and author who gained national attention for opposing vaccine ...